These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 34192639

  • 1. Optimizing outcomes using vancomycin therapeutic drug monitoring in patients with MRSA bacteremia: trough concentrations or area under the curve?
    Johnston MM, Huang V, Hall ST, Buckley MS, Bikin D, Barletta JF.
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115442. PubMed ID: 34192639
    [Abstract] [Full Text] [Related]

  • 2. Comparison of Vancomycin Area-Under-the-Curve Dosing Versus Trough Target-Based Dosing in Obese and Nonobese Patients With Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Covvey JR, Erickson O, Fiumara D, Mazzei K, Moszczenski Z, Slipak K, Nemecek BD, Zimmerman DE, Guarascio AJ.
    Ann Pharmacother; 2020 Jul; 54(7):644-651. PubMed ID: 31888350
    [Abstract] [Full Text] [Related]

  • 3. Implementation of a two-point pharmacokinetic AUC-based vancomycin therapeutic drug monitoring approach in patients with methicillin-resistant Staphylococcus aureus bacteraemia.
    Mogle BT, Steele JM, Seabury RW, Dang UJ, Kufel WD.
    Int J Antimicrob Agents; 2018 Dec; 52(6):805-810. PubMed ID: 30176357
    [Abstract] [Full Text] [Related]

  • 4. Vancomycin Trough Concentration as a Predictor of Clinical Outcomes in Patients with Staphylococcus aureus Bacteremia: A Meta-analysis of Observational Studies.
    Prybylski JP.
    Pharmacotherapy; 2015 Oct; 35(10):889-98. PubMed ID: 26497475
    [Abstract] [Full Text] [Related]

  • 5. Impact of initial vancomycin pharmacokinetic/pharmacodynamic parameters on the clinical and microbiological outcomes of methicillin-resistant Staphylococcus aureus bacteremia in children.
    Yoo R, So H, Seo E, Kim M, Lee J.
    PLoS One; 2021 Oct; 16(4):e0247714. PubMed ID: 33793589
    [Abstract] [Full Text] [Related]

  • 6. Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.
    Kullar R, Davis SL, Levine DP, Rybak MJ.
    Clin Infect Dis; 2011 Apr 15; 52(8):975-81. PubMed ID: 21460309
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of vancomycin population susceptibility analysis profile as a predictor of outcomes for patients with infective endocarditis due to methicillin-resistant Staphylococcus aureus.
    Casapao AM, Davis SL, McRoberts JP, Lagnf AM, Patel S, Kullar R, Levine DP, Rybak MJ.
    Antimicrob Agents Chemother; 2014 Aug 15; 58(8):4636-41. PubMed ID: 24890596
    [Abstract] [Full Text] [Related]

  • 8. The monitoring of vancomycin: a systematic review and meta-analyses of area under the concentration-time curve-guided dosing and trough-guided dosing.
    Tsutsuura M, Moriyama H, Kojima N, Mizukami Y, Tashiro S, Osa S, Enoki Y, Taguchi K, Oda K, Fujii S, Takahashi Y, Hamada Y, Kimura T, Takesue Y, Matsumoto K.
    BMC Infect Dis; 2021 Feb 06; 21(1):153. PubMed ID: 33549035
    [Abstract] [Full Text] [Related]

  • 9. Establishment of an AUC0-24 Threshold for Nephrotoxicity Is a Step towards Individualized Vancomycin Dosing for Methicillin-Resistant Staphylococcus aureus Bacteremia.
    Chavada R, Ghosh N, Sandaradura I, Maley M, Van Hal SJ.
    Antimicrob Agents Chemother; 2017 May 06; 61(5):. PubMed ID: 28242672
    [Abstract] [Full Text] [Related]

  • 10. Association between single trough-based area under the curve estimation of vancomycin and treatment outcome among methicillin-resistant Staphylococcus aureus bacteremia patients.
    Makmor-Bakry M, Ahmat A, Shamsuddin A, Lau CL, Ramli R.
    Anaesthesiol Intensive Ther; 2019 May 06; 51(3):218-223. PubMed ID: 31434472
    [Abstract] [Full Text] [Related]

  • 11. Vancomycin exposure in patients with methicillin-resistant Staphylococcus aureus bloodstream infections: how much is enough?
    Lodise TP, Drusano GL, Zasowski E, Dihmess A, Lazariu V, Cosler L, McNutt LA.
    Clin Infect Dis; 2014 Sep 01; 59(5):666-75. PubMed ID: 24867791
    [Abstract] [Full Text] [Related]

  • 12. Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia.
    Song KH, Kim HB, Kim HS, Lee MJ, Jung Y, Kim G, Hwang JH, Kim NH, Kim M, Kim CJ, Choe PG, Chung JY, Park WB, Kim ES, Park KU, Kim NJ, Kim EC, Oh MD.
    Int J Antimicrob Agents; 2015 Dec 01; 46(6):689-95. PubMed ID: 26555059
    [Abstract] [Full Text] [Related]

  • 13. Conversion from Vancomycin Trough Concentration-Guided Dosing to Area Under the Curve-Guided Dosing Using Two Sample Measurements in Adults: Implementation at an Academic Medical Center.
    Meng L, Wong T, Huang S, Mui E, Nguyen V, Espinosa G, Desai J, Holubar M, Deresinski S.
    Pharmacotherapy; 2019 Apr 01; 39(4):433-442. PubMed ID: 30739349
    [Abstract] [Full Text] [Related]

  • 14. Cost comparison of AUC:MIC- versus trough-based vancomycin monitoring for MRSA bacteremia.
    Beccari MV, Seabury RW, Mogle BT, Kufel WD, Miller CD, Steele JM.
    J Am Pharm Assoc (2003); 2020 Apr 01; 60(5):729-733. PubMed ID: 32224054
    [Abstract] [Full Text] [Related]

  • 15. Are Vancomycin Trough Concentrations of 15 to 20 mg/L Associated With Increased Attainment of an AUC/MIC ≥ 400 in Patients With Presumed MRSA Infection?
    Hale CM, Seabury RW, Steele JM, Darko W, Miller CD.
    J Pharm Pract; 2017 Jun 01; 30(3):329-335. PubMed ID: 27074786
    [Abstract] [Full Text] [Related]

  • 16. Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia.
    Jung Y, Song KH, Cho Je, Kim HS, Kim NH, Kim TS, Choe PG, Chung JY, Park WB, Bang JH, Kim ES, Park KU, Park SW, Kim HB, Kim NJ, Oh MD.
    Int J Antimicrob Agents; 2014 Feb 01; 43(2):179-83. PubMed ID: 24315788
    [Abstract] [Full Text] [Related]

  • 17. Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.
    Moise PA, Culshaw DL, Wong-Beringer A, Bensman J, Lamp KC, Smith WJ, Bauer K, Goff DA, Adamson R, Leuthner K, Virata MD, McKinnell JA, Chaudhry SB, Eskandarian R, Lodise T, Reyes K, Zervos MJ.
    Clin Ther; 2016 Jan 01; 38(1):16-30. PubMed ID: 26585355
    [Abstract] [Full Text] [Related]

  • 18. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Gawronski KM, Goff DA, Brown J, Khadem TM, Bauer KA.
    Clin Ther; 2013 Jun 01; 35(6):772-9. PubMed ID: 23795575
    [Abstract] [Full Text] [Related]

  • 19. Association Between Vancomycin Trough Concentrations and Duration of Methicillin-Resistant Staphylococcus aureus Bacteremia in Children.
    Hsu AJ, Hamdy RF, Huang Y, Olson JA, Ghobrial S, Gerber JS, Hersh AL, Tamma PD.
    J Pediatric Infect Dis Soc; 2018 Dec 03; 7(4):338-341. PubMed ID: 28992126
    [Abstract] [Full Text] [Related]

  • 20. The Impact of AUC-Based Monitoring on Pharmacist-Directed Vancomycin Dose Adjustments in Complicated Methicillin-Resistant Staphylococcus aureus Infection.
    Stoessel AM, Hale CM, Seabury RW, Miller CD, Steele JM.
    J Pharm Pract; 2019 Aug 03; 32(4):442-446. PubMed ID: 29554847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.